Background: Novel Corona virus infection (SARS-CoV-2), also known as COVID-19 in pregnancy is an important concern but currently limited data available to predict the risk of virus infection in pregnancy and its adverse outcome.

Methods: In our prospective observational study, total 1120 pregnant women admitted in the isolation ward of our institution were included.  All women presented with common symptoms like fever, tiredness, headache, sore throat, and cough.

Results: Sixty women were diagnosed SARS-CoV-2/COVID-19 positive by Reverse Transcriptase Polymerase Chain Reaction (RTPCR) examination of nasopharyngeal swab (NP), which was almost 5.3% of the isolated women. All neonates were tested negative for SARS-CoV-2 infection. All the study subjects recovered with routine care and were sent home after 7 days with advice for “safe home” (facility for asymptomatic patients who does not need specialized care) for further 7 days.

Conclusions: SARS-CoV-2 infection in pregnancy most of the time presents in the latter half of pregnancy and management is similar to that in the general population. There is no increased risk of severe disease during pregnancy. Support of intimate partner, social support will make the hygiene of mental health amongst the COVID positive mother. Neonates mostly protected from disease transmission due to immune modulation during pregnancy.

Keywords: Corona Virus, Pregnancy, SARS, COVID 19, RTPCR

Click Here For Reading Continue

For Download  :